Development of an Oral Delivery System for COVID-19 Vaccines Using Thin Polymer Strips

使用薄聚合物条开发 COVID-19 疫苗口服给药系统

• 批准号: 555039-2020
• 负责人: Adronov, Alex
• 金额: $ 3.64万
• 依托单位: McMaster University
• 依托单位国家: 加拿大
• 项目类别: Alliance Grants
• 财政年份: 2020
• 资助国家: 加拿大
• 起止时间: 2020-01-01 至 2021-12-31
• 项目状态: 已结题
• 来源: https://www.nserc-crsng.gc.ca/ase-oro/Details-Detailles_eng.asp?id=705592
• 关键词: Development; Oral; Delivery; System; COVID

To overcome the current pandemic, a vaccine will need to be developed. However, conventional vaccination via sub-cutaneous injection is expensive, time-consuming, and operationally complex; it will require many months or even years to complete, significantly prolonging the pandemic recovery process. This project aims to develop a robust, convenient, and easily administered delivery system for the eventual SARS-COV-2 vaccine, avoiding sub-cutaneous injection and the requirement for trained healthcare professionals in the vaccination process. This system will use thin polymer strips that dissolve rapidly (within several seconds) in the mouth and are loaded with viral antigens, providing an alternative vehicle that can easily and conveniently deliver a precise dose of vaccine to the sub-lingual mucosa. It has already been shown that sub-lingual vaccine delivery in liquid form is effective in producing an immune response to a variety of infectious agents. This project will advance these results to the thin-film platform, allowing vaccinations to be carried out in an operationally simple manner, and enabling the pace of global vaccination to dramatically increase.

为了克服当前的大流行，需要开发疫苗。然而，传统的皮下注射疫苗价格昂贵、耗时且操作复杂；这将需要数月甚至数年的时间才能完成，从而大大延长了大流行病的恢复过程。该项目旨在为最终的 SARS-COV-2 疫苗开发一种强大、方便且易于管理的输送系统，避免皮下注射，并且在疫苗接种过程中不需要训练有素的医疗保健专业人员。该系统将使用薄聚合物条，在口腔中快速溶解（几秒钟内）并装载病毒抗原，提供一种替代载体，可以轻松方便地将精确剂量的疫苗递送到舌下粘膜。 已经证明，以液体形式舌下注射疫苗可有效产生针对多种感染原的免疫反应。 该项目将把这些成果推进到薄膜平台，使疫苗接种能够以操作简单的方式进行，并使全球疫苗接种的步伐大幅加快。